Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 11.41 is strong.
Chongqing Xishan Science and Technology Co has a Altman Z-Score of 11.63, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
Chongqing Xishan Science and Technology Co (SHSE:688576) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co Altman Z-Score Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: Altman Z-Score Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Chongqing Xishan Science and Technology Co's Altman Z-Score falls into.
Chongqing Xishan Science and Technology Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a Altman Z-Score of 11.63 as of Jul. 28, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Chongqing Xishan Science and Technology Co and its competitors. This is 22% below median its historical median of 14.83. Over the past decade, Chongqing Xishan Science and Technology Co's Altman Z-Score has ranged from 11.32 to 45.73. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #105 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 13%.
Is Chongqing Xishan Science and Technology Co's Altman Z-Score too high?
Chongqing Xishan Science and Technology Co's current Altman Z-Score of 11.63 is 22% below median its 10-year median of 14.83. Over the past 10 years, this metric has ranged from a low of 11.32 to a high of 45.73. The Medical Devices & Instruments industry median Altman Z-Score is 2.95. Chongqing Xishan Science and Technology Co's value of 11.63 is 294.2% above this industry median. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #105 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #105 out of 805 companies for Altman Z-Score. This places Chongqing Xishan Science and Technology Co in the top 13% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.95. Chongqing Xishan Science and Technology Co's value of 11.63 is 294.2% above this benchmark. Historically, Chongqing Xishan Science and Technology Co's own Altman Z-Score has ranged from 11.32 to 45.73 over the past decade. While the company's 10-year median is 14.83 vs. the industry median of 2.95, Chongqing Xishan Science and Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.95, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chongqing Xishan Science and Technology Co's current Altman Z-Score of 11.63 is 294.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current Altman Z-Score is 11.63, which is 22% below median its own 10-year median of 14.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥53.66, compared to a current price of ¥36.33 — trading 32.3% below its estimated fair value. The current Altman Z-Score is 11.63, which is 22% below median its 10-year median of 14.83 and 294.2% above the Medical Devices & Instruments industry median of 2.95. Chongqing Xishan Science and Technology Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current Altman Z-Score is 11.63 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥36.33 is trading 32.3% below its estimated GF Value™ of ¥53.66.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688576:
Altman Z-Score: 11.63 (22% below median its 10-year median of 14.83)
GF Value™: ¥53.66 vs. price of ¥36.33 (32.3% below fair value)
Industry Position: 294.2% above the Medical Devices & Instruments median (#105 of 805)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chongqing Xishan Science and Technology Co Business Description
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
85GF Score
Get the complete analysis for SHSE:688576
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
